How to appeal your OptumRx step therapy override denial

Why OptumRx denies step therapy override

OptumRx is UnitedHealth Group's pharmacy benefit manager and administers drug coverage for UHC commercial and Medicare Part D plans, plus many third-party employer groups. The appeal track mirrors UHC procedurally but is filed and decided separately from the medical benefit.

For step therapy override specifically: Step therapy (also called 'fail-first') requires patients to try a plan-preferred medication and demonstrate failure or intolerance before the plan will cover the prescribed drug. Federal and many state laws require plans to allow exception requests when the step is clinically inappropriate.

What OptumRx denies for step therapy override

The step therapy override services most often denied:

• Biologics for rheumatoid arthritis, psoriasis, Crohn's, ulcerative colitis
• MS disease-modifying therapies
• GLP-1s when a less-effective oral is preferred
• Newer migraine therapies (CGRP inhibitors)
• Specialty oncology when older regimens are preferred

Why step therapy override claims get denied

A typical OptumRx step therapy override denial almost always cites one of these reasons. Each one maps to a specific rebuttal in the appeal:

• Patient has not tried and failed the preferred drug
• Documentation of prior trial / failure is incomplete
• Plan does not recognize prior trial done under previous plan
• Contraindication or intolerance not documented in record

The OptumRx appeal process

Appeal levels: Coverage determination / exception request, then plan-level redetermination, then external review (IRO commercial; IRE / MAXIMUS for Part D).

Carrier timing: Standard exception: 72 hours. Expedited: 24 hours. Redetermination filing window: 60 days for Part D, 180 days for commercial.

Step therapy timing: Standard exception: typically 72 hours. Expedited urgent: 24 hours. Most state step-therapy override laws require response within 72 hours or less.

What we know about OptumRx: Where the medical and pharmacy benefits both touch the same therapy (e.g. provider-administered biologics), we file parallel appeals in both lanes to avoid a procedural gap.

Common OptumRx denial patterns for step therapy override

• Separate appeal track from UHC medical. An OptumRx denial is not a UHC medical denial, and vice versa. Filing the wrong appeal track is one of the most common preventable errors. We confirm whether the denial originated at the pharmacy benefit or the medical benefit before filing.
• Specialty drug routing through BriovaRx / Optum Specialty. Specialty injectables and infused biologics often route through Optum's specialty pharmacy. Denials at this layer require formulary-exception documentation with clinical rationale, prior-trial data, and (where applicable) FDA-label citation.
• Part D coverage determinations. OptumRx-administered Part D plans follow the federal 5-level Part D appeal ladder. The IRE for Part D escalation is MAXIMUS Federal Services. Tiering and formulary exceptions are filed before a coverage-determination challenge.

How to win your OptumRx step therapy override appeal

Strategy for step therapy override: File a step-therapy override request citing one of the standard override grounds: (1) prior trial and failure of the preferred drug, (2) contraindication to the preferred drug, (3) intolerance / adverse reaction, (4) likely-ineffective based on clinical characteristics, or (5) stability on current therapy. Attach prior pharmacy records from any plan to demonstrate prior trials. Many state laws now codify a tight response timeline for step-therapy overrides, cite the applicable statute.

Filed against OptumRx, that strategy rides on this procedural spine:

1. Procedural-rights anchor. Every OptumRx denial triggers ERISA § 503 or 45 C.F.R. § 147.136 procedural rights. The cover letter invokes these in the opening paragraph to lock the timeline and force criteria disclosure.
2. Criteria-disclosure demand. OptumRx frequently denies on "not medically necessary" without disclosing the clinical criteria applied. Once disclosed, those criteria become the rebuttal map.
3. Controlling-standard citation. Federal and state step-therapy override laws require an exception for contraindication, intolerance, prior failure, or likely ineffectiveness.
4. Treating-provider attestation. A letter from the treating physician addressing each criterion in OptumRx's own policy language. This is the single strongest evidentiary element.
5. Requested action. A specific demand to reverse the step therapy override denial and approve the service, not a general "please reconsider."

Documents you'll need for your OptumRx step therapy override appeal

• Denial letter
• Prescription record from current and prior plans
• Prescriber's letter documenting clinical rationale and any prior trials
• Documentation of contraindication or intolerance (if applicable)
• Relevant lab values or imaging supporting indication

What a step therapy override appeal can recover

Typical recovery for step therapy override cases runs $500 - $30,000+ per month of medication. The exact figure depends on the specific service and your plan's contracted rates.

OptumRx step therapy override appeals: frequently asked questions

What Apellica does for OptumRx step therapy override appeals

We file appeals against OptumRx specifically configured to its internal review process. Every step therapy override appeal embeds the criteria-disclosure demand, the procedural-rights anchor, the controlling-standard citation above, treating-provider attestation language, and the peer-reviewed evidence relevant to the denied service.

Cost: $0 upfront. We work on contingency for OptumRx appeals, if the appeal succeeds, we collect a percentage of the recovered claim value. If it fails, you owe nothing.

Related OptumRx guides

• OptumRx surgery denials appeal guide
• OptumRx mri and imaging denials appeal guide
• OptumRx medication and prescription denials appeal guide
• OptumRx medicare denials appeal guide

Step therapy override guides for other carriers

• UnitedHealthcare step therapy override appeal guide
• Aetna (CVS Health) step therapy override appeal guide
• Cigna (Evernorth) step therapy override appeal guide
• Anthem / BlueCross BlueShield step therapy override appeal guide